SCHEMBL6565876

SCHEMBL6565876

CCOc1c(C(C)(C)C)cc(CCCO)cc1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 1/20 0.39
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
PPARA Q07869 1/20 0.36
VCAM1 P19320 2/20 0.35
GSR P00390 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 2/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
GMNN O75496 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567740 0.91 CYP4F2 (0.37) TNKS2CYP4F2CYP4A11HTR2AHTR2C
SCHEMBL6568715 0.83 TNKS2 (0.49) TNKS2CYP4A11PPARAVCAM1GSR
SCHEMBL7940177 0.83 VCAM1 (0.40) TNKS2CYP4F2CYP4A11VCAM1ALDH1A1
SCHEMBL7940366 0.82 VCAM1 (0.41) CYP4F2CYP4A11VCAM1ALDH1A1
SCHEMBL7942347 0.81 CNR2 (0.40) CYP4F2CYP4A11VCAM1GAAKMT2A
SCHEMBL7933682 0.81 CYP4F2 (0.43) CYP4F2CYP4A11VCAM1GAAKMT2A
SCHEMBL22277897 0.81 TNKS2 (0.37) TNKS2CYP4F2CYP4A11PPARAVCAM1
SCHEMBL7943173 0.80 CYP4F2 (0.42) CYP4F2CYP4A11VCAM1GAAKMT2A
SCHEMBL6565780 0.80 CALM1 (0.41) CYP4F2CYP4A11PPARAALDH1A1KDM4E
SCHEMBL6567747 0.78 HSPA5 (0.41) CYP4F2CYP4A11VCAM1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1484334-A2 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-08 EP disclosed
US-20040225145-A1 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED 2004-11-11 US disclosed
EP-0823435-B1 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL CO (JP) 2001-11-21 EP disclosed
US-5914361-A IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-06-22 US disclosed
US-5889095-A OXYGEN AND HEAT RESISTANCE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1999-03-30 US disclosed
EP-0823435-A2 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040225145-A1 Process for producing phosphite PHOSPHO1, PLCG1, PLCG2 TNKS2 3019/4885CYP4F2 387/4885CYP4A11 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.